selinexor in multiple myeloma — dr. joshua richter | mcrt webcast july 11
Published 3 years ago • 719 plays • Length 10:16Download video MP4
Download video MP3
Similar videos
-
3:04
what are celmods in multiple myeloma (& when will they be available?) | dr. joshua richter
-
2:18
t cell re-direction therapy | joshua richter, md | eha 2022
-
3:11
bispecific antibodies | joshua richter, md | ash 2022
-
1:03:56
selinexor combinations in clinical trials with dr. jeffrey zonder
-
57:58
how often should mrd testing occur during remission (and an mrd overview) with dr. joshua richter
-
2:25
cevostamab in rrmm patients: camma 2 study results | joshua richter, md | eha 2024
-
5:20
what are bispecifics in multiple myeloma? (for patients and caregivers) | dr. joshua richter
-
54:41
exploring the selinexor stomp trial
-
31:15
multiple myeloma in 2023: what patients & caregivers need to know now! | the patient story
-
31:04
thriving with myeloma: what you should know about care and treatment
-
8:18
what is multiple myeloma? - drs. landgren and gertz
-
2:01
dr. joshua richter discusses multiple myeloma clinical trials
-
21:02
emerging bispecifics myeloma patients should know about | dr. joshua richter | the patient story
-
2:03
ash 2018: selexinor results in tow trials: storm and stomp
-
1:07:46
healthtree podcast for myeloma: joshua richter, md, mount sinai covid update
-
2:18
preventing and monitoring infections with immune therapies | joshua richter, md | ims 2023
-
11:11
rationale for selinexor treatment in daratumumab-refractory multiple myeloma patients
-
1:28
regeneron bispecific antibody targeting bcma update | joshua richter, md | ash 2021
-
1:57
dr. chari on using selinexor in multiple myeloma treatment
-
5:51
understanding selinexor: david siegel, md, phd
-
1:21
dr. friedman on the future of selinexor in multiple myeloma
-
1:02
the role of selinexor in the treatment of multiple myeloma